Complications of diabetes and metrics of glycemic management derived from continuous glucose monitoring

M Yapanis, S James, ME Craig… - The Journal of …, 2022 - academic.oup.com
Context Although glycated hemoglobin A1c is currently the best parameter used clinically to
assess risk for the development of diabetes complications, it does not provide insight into …

Type 1 diabetes mellitus

A Katsarou, S Gudbjörnsdottir, A Rawshani… - Nature reviews Disease …, 2017 - nature.com
Type 1 diabetes mellitus (T1DM), also known as autoimmune diabetes, is a chronic disease
characterized by insulin deficiency due to pancreatic β-cell loss and leads to …

The National Lipid Association scientific statement on coronary artery calcium scoring to guide preventive strategies for ASCVD risk reduction

CE Orringer, MJ Blaha, R Blankstein, MJ Budoff… - Journal of clinical …, 2021 - Elsevier
Abstract An Expert Panel of the National Lipid Association reviewed the evidence related to
the use of coronary artery calcium (CAC) scoring in clinical practice for adults seen for …

Type 1 diabetes mellitus and cardiovascular disease: a scientific statement from the American Heart Association and American Diabetes Association

SD De Ferranti, IH De Boer, V Fonseca, CS Fox… - Circulation, 2014 - Am Heart Assoc
(CVD) in individuals with type 1 diabetes mellitus (T1DM), the pathophysiology underlying
the relationship between cardiovascular events, CVD risk factors, and T1DM is not well …

Insulin resistance and hyperglycaemia in cardiovascular disease development

M Laakso, J Kuusisto - Nature reviews endocrinology, 2014 - nature.com
The prevalence of diabetes mellitus will likely increase globally from 371 million individuals
in 2013 to 552 million individuals in 2030. This epidemic is mainly attributable to type 2 …

Insulin resistance is a cardiovascular risk factor in humans

MM Adeva-Andany, J Martínez-Rodríguez… - Diabetes & Metabolic …, 2019 - Elsevier
Diabetes is a common metabolic disorder associated to elevated cardiovascular morbidity
and mortality that is not explained by hyperglycemia or traditional cardiovascular risk factors …

American Association of Clinical Endocrinologists and American College of Endocrinology guidelines for management of dyslipidemia and prevention of …

PS Jellinger, Y Handelsman, PD Rosenblit… - Endocrine Practice, 2017 - Elsevier
Objective The development of these guidelines is mandated by the American Association of
Clinical Endocrinologists (AACE) Board of Directors and American College of Endocrinology …

Risk of all-cause mortality and vascular events in women versus men with type 1 diabetes: a systematic review and meta-analysis

RR Huxley, SAE Peters, GD Mishra… - The lancet Diabetes & …, 2015 - thelancet.com
Background Studies have suggested sex differences in the mortality rate associated with
type 1 diabetes. We did a meta-analysis to provide reliable estimates of any sex differences …

American Association of Clinical Endocrinologists' guidelines for management of dyslipidemia and prevention of atherosclerosis

PS Jellinger, DA Smith, AE Mehta, O Ganda… - Endocrine …, 2012 - endocrinepractice.org
METHODS This CPG was developed in accordance with the AACE Protocol for
Standardized Production of Clinical Practice Guidelines—2010 Update (

Pathogenesis of lipid disorders in insulin resistance: a brief review

P Bjornstad, RH Eckel - Current diabetes reports, 2018 - Springer
Purpose of review Insulin resistance (IR) is recognized to play an important role in the
pathogenesis of dyslipidemia. This review summarizes the complex interplay between IR …